ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,382,000 | -7.4% | 11,009 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,493,000 | -7.7% | 11,009 | -12.9% | 0.00% | -25.0% |
Q4 2020 | $1,618,000 | +13.8% | 12,642 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,422,000 | +18.0% | 12,642 | -0.1% | 0.00% | 0.0% |
Q2 2020 | $1,205,000 | +6.0% | 12,651 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,137,000 | -18.0% | 12,651 | -55.7% | 0.00% | -20.0% |
Q2 2018 | $1,386,000 | +94.4% | 28,578 | +6.2% | 0.01% | +66.7% |
Q1 2017 | $713,000 | +59.9% | 26,920 | +54.0% | 0.00% | +50.0% |
Q4 2016 | $446,000 | -29.5% | 17,480 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $633,000 | -65.5% | 17,480 | -53.5% | 0.00% | -66.7% |
Q4 2015 | $1,835,000 | +142.4% | 37,630 | +23.7% | 0.01% | +125.0% |
Q3 2015 | $757,000 | -35.8% | 30,420 | -18.4% | 0.00% | -42.9% |
Q2 2015 | $1,179,000 | -16.9% | 37,270 | 0.0% | 0.01% | -12.5% |
Q1 2015 | $1,418,000 | -2.4% | 37,270 | -0.1% | 0.01% | 0.0% |
Q4 2014 | $1,453,000 | +19.2% | 37,300 | -7.4% | 0.01% | +14.3% |
Q3 2014 | $1,219,000 | – | 40,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |